XML 25 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity-Based Compensation
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Equity-Based Compensation

Note 3: Equity-Based Compensation

 

The fair value of each option and equity warrant award is estimated on the date of grant using a Black-Scholes-Merton option pricing valuation model. Expected volatility is based on the historical volatility of the price of the Company’s stock. The risk-free interest rate is based on U.S. Treasury issues with a term equal to the expected life of the option and equity warrant. The Company uses historical data to estimate expected dividend yield, expected life and forfeiture rates. There were 300,000 options granted in the nine months ended September 30, 2022, and no options granted in the nine months ended September 30, 2021.

 

Stock option for employees’ activity during the nine months ended September 30, 2022, is as follows:

 

Stock option activity for employees:

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Outstanding January 1, 2021   1,498,798   $4.22    9.11   $ 
Granted   150,000    0.70    9.17     
Forfeited   (1,684)   117.6         
Expired                
Outstanding September 30, 2022   1,647,114   $3.78    8.43   $ 
Vested and expected to vest September 30, 2022   1,647,114   $3.78    8.43   $ 
Exercisable September 30, 2022   1,542,949   $2.43    6.66   $ 

 

 

Unvested stock option activity for employees:

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Unvested January 1, 2022   412,500   $4.15    5.85   $ 
Granted   150,000    0.70    9.17     
Expired   (1,684)   117.6         
Vested   (456,651)   1.43         
Unvested September 30, 2022   104,165   $6.52    3.14   $ 

 

Stock option activity for non-employees:

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term (Years)
   Aggregate
Intrinsic
Value
 
Outstanding January 1, 2022   279,723   $6.12    7.93   $ 
Granted   150,000    0.70    9.42     
Forfeited                
Expired                
Outstanding September 30, 2022   429,723   $4.10    7.96   $ 
Vested and expected to vest September 30, 2022   429,723   $4.10    7.96   $ 
Exercisable September 30, 2022   354,526   $4.21    8.32   $ 

 

Unvested stock option activity for non-employees:

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
   Aggregate
Intrinsic
Value
 
Unvested January 1, 2022   97,831   $3.89    7.82   $ 
Granted   150,000    0.70    9.42     
Expired                
Vested   (172,634)   1.16         
Unvested September 30, 2022   75,197   $3.79    8.24   $ 

 

Stock-based compensation expense was approximately $792,000 and $1,320,000 for the nine months ended September 30, 2022, and 2021, resulting in an increase in general and administrative expenses, respectively.

 

As of September 30, 2022, and 2021, respectively, there was approximately $179,000 and $279,000 of unrecognized equity-based compensation cost related to options granted under the Equity Incentive Plan.